Therapeutic Advances in Chronic Disease-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2022-05-02 1510122720

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：心血管
经验分享：比较友好，1月投稿，3月返修，4月底接收

133 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-17 MS9985544

审稿速度:3.0 | 投稿命中率:50.0
经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！

177 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2022-06-15 ms8000000558825325

已经第5个审稿人了啊

175 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2022-01-10 ms2000000561444460

厉害了

97 0

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-29 rayms

通讯作者最多有多少个？同第一作者最多有多少个？

218 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-29 小动量

同一杂志社不同期刊如何转投（transfer）？

133 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-17 MS98494985

46天收到初审消息，我觉得还可以，不是特别急的可以投

165 0

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-17 MS754689849

审稿速度:3.0 | 投稿命中率:50.0
经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。

145 0

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-17 MS98545456

一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。

137 0

[GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：比较友好，1月投稿，3月返修，4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：今年投了一篇meta，初审返修1个半月，直到收信确定接受总共历时4个月，对我来说命中概率较高.不知道对你们来说这个算不算快？但是我觉得这个期刊还是很不错，主要是我的文章被接受了，是我写得好还是杂志好？哈哈哈，我觉得这个杂志还是可以考虑的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182968, encodeId=45d4118296862, content=厉害了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bebf6458454, createdName=ms2000000561444460, createdTime=Mon Jan 10 21:48:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081354, encodeId=abb410813540d, content=46天收到初审消息，我觉得还可以，不是特别急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98494985, createdTime=Fri Dec 17 23:09:27 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081352, encodeId=101c108135212, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：8月提交，9月中返修。评审给了很多意见修改，感觉是比较严苛的。11月提交修改，这个月收到了回复，评审满意，预计应该明年可以online了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS754689849, createdTime=Fri Dec 17 23:08:31 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081350, encodeId=101510813501a, content=一审差不都1个半，二审一个月，然后修回后近1个月接收，请问谁知道接收后多久能online？编辑建议open access，不知能否将online时间提前。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS98545456, createdTime=Fri Dec 17 23:07:35 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081346, encodeId=a0c41081346db, content=这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS56888777, createdTime=Fri Dec 17 23:05:45 CST 2021, time=2021-12-17, status=1, ipAttribution=)]

2021-12-17 MS56888777

这个期刊影IF升的的确比较快，看着它从4分到5分多，但是审稿相对还是挺严格的，如果文章不够质量，拒稿很快。。。还是要写好一点质量的文章，毕竟影响影子5.091，不是水刊

104 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务